SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
DELTAGEN INC
(NQPK:DGEN Last Sale: .04 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (DGEN : $.04)
$2 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
1003 Hamilton Avenue Research Report Earnings Snapshot - Last 09/10/14
Menlo Park, CA 94025 Fact Sheet
Phone: (650) 752-0200 Financial Statements
Fax: (650) 752-0202 Peer Comparison
Annual Reports

Nicholas J. Simon, Chmn., William Matthews, Pres./CEO, Richard Hawkins, CFO
Provides a database of mammalian gene functions and a target-validation program to select and validate drug-discovery targets. IPO at $15 August 2, 2000. Raised $105.0 million, selling 7.0 million shares, 24% of the outstanding. Lead Manager: Citigroup / Salomon Smith Barney.
Historical Charts    Technical Analysis
No Historical Data available for DGEN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common DGEN $.04 $ 0 $.04 $.04 1,000 $.008 $.05 38,852
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $1,554

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex